Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice. [electronic resource]
Producer: 19920306Description: 493-9 p. digitalISSN:- 0020-7136
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma -- drug therapy
- Cell Division -- drug effects
- Cyclophosphamide -- administration & dosage
- Cytotoxicity, Immunologic -- drug effects
- Interleukin-2 -- administration & dosage
- Male
- Mice
- Mice, Inbred C57BL
- Neoplasms, Experimental -- drug therapy
- Spleen -- cytology
- Thymalfasin
- Thymosin -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.